Shares of Divi's Laboratories on Monday zoomed 15 per cent to a fresh 52-week high of Rs 3,201.85 on the BSE after reporting 80.61 per cent year-on-year (YoY) rise in consolidated net profit for the June quarter of 2020-21 (Q1FY21).
The drug firm reported a net profit of Rs 492.06 crore for the quarter on account of robust sales. In comparison, the company had logged a profit of Rs 272.44 crore in the year-ago same period, Divi's Laboratories said in a filing to BSE.
Total income stood at Rs 1,747.80 crore during the quarter under review as against Rs 1,193.20 crore in